Send feedback

ADA p.Lys312Arg

c.935A>G · rs748974674 · VCV1507601

Uncertain significance Expert panel
Classification
Uncertain significance
ClinVar
Review
Expert panel ★★★☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.0765 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000339%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency

ClinGen expert panel — Severe Combined Immunodeficiency Disease VCEP

Uncertain Significance for adenosine deaminase deficiency. Applied ACMG criteria (verbatim):

PM2_Supporting

Curation rationale (ClinGen, verbatim)

The c.935A>G (NM_000022.4) variant in ADA is a missense variant predicted to cause substitution of Lysine by Arginine at amino acid 312 (p.Lys312Arg). The filtering allele frequency (the upper threshold of the 95% CI of (4/418132 alleles) of the c.935A>G variant in ADA is 0.000003240 for European (non-Finnish) chromosomes by gnomAD v4, which is lower than the ClinGen SCID VCEP threshold (<0.0001742) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). No homozygotes have been observed in gnomAD. Another missense variant [c.934A>C, p.Lys312Gln] in the same codon has been reported; however, the ClinGen SCID VCEP classified this variant as VUS (PM5 not met). To our knowledge, this variant has not been reported in the literature in individuals affected with ADA-related conditions or in functional studies. Due to insufficient evidence, this variant is classified as a variant of uncertain significance for autosomal recessive SCID based on ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP (specification version 1.0): PM2_Supporting.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.0765likely benign
REVEL0.344indeterminate
SaProtLLR -5.28tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3.4GERP 1.7, phastCons 1
Regional constrainto/e 0.94unconstrained · MANE · 32 kb · p 0.21 · regional, not allelic
Overall
CADD18.35PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000339% European (non-Finnish) · 4/1,180,036 alleles
Filtering AF 7.9e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.4e-05%
Overall 0.000248% 4/1,614,036 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ADA
Protein
p.Lys312Arg
Coding
c.935A>G
MANE Select
NM_000022
dbSNP
rs748974674
Type
single nucleotide variant
Location
chr20:44621058 (GRCh38)
Gene constraint
LOEUF 1.184 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 96.81 · 2 PDB
Residue 312
an α-helix
Full ADA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Severe combined immunodeficiency due to adenosine deaminase deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal
Prevalence
1-9 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ada-p-lys312arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown